Grape seed proanthocyanidin extract alleviates ouabain-induced vascular remodeling through regulation of endothelial function

Molecular Medicine Reports

Volumn 6, Issue 5, 2012, Pages 949-954

  Liu, Xiangju ^a,b   Qiu, Jie ^a,b   Zhao, Shaohua ^a,b   You, Beian ^a,b   Ji, Xiang ^a,b   Wang, Yan ^a,b   Cui, Xiaopei ^a   Wang, Qian ^a   Gao, Haiqing ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Provincial Key Laboratory of Cardiovascular Proteomics   (China)

Author keywords

Grape seed proanthocyanidin extract; Hypertension; Ouabain; Rats; Vascular remodeling

Indexed keywords

ENDOTHELIN 1; GRAPE SEED EXTRACT; MESSENGER RNA; NITRIC OXIDE; OUABAIN; PROANTHOCYANIDIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERTENSION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GRAPE SEED EXTRACT; MALE; NITRIC OXIDE; OUABAIN; PROANTHOCYANIDINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEEDS; TRANSFORMING GROWTH FACTOR BETA1; VITIS;

RATTUS; STROPHANTHUS GRATUS; VITACEAE;

EID: 84866465386     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1026     Document Type: Article

References (27)

1. Rudic RD and Sessa WC: Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am J Hum Genet 64: 673-677, 1999. (Pubitemid 30460407)
2. Langille BL and O'Donnell F: Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405-407, 1986. (Pubitemid 16108652)
3. Ghosh J, Murphy MO, Turner N, Khwaja N, Halka A, Kielty CM and Walker MG: The role of transforming growth factor beta1 in the vascular system. Cardiovasc Pathol 14: 28-36, 2005. (Pubitemid 40248430)
4. Shao ZH, Becker LB, Vanden Hoek TL, Schumacker PT, Li CQ, Zhao D, Wojcik K, Anderson T, Qin Y, Dey L and Yuan CS: Grape seed proanthocyanidin extract attenuates oxidant injury in cardiomyocytes. Pharmacol Res 47: 463-469, 2003. (Pubitemid 36542924)
5. Heimark, RL, Twardzik DR and Schwartz SM: Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233: 1078-1080, 1986. (Pubitemid 16032237)
6. Li RK, Li G, Mickle DA, Weisel RD, Merante F, Luss H, Rao V, Christakis GT and Williams WG: Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy.Circulation 96: 874-881, 1997. (Pubitemid 27329622)
7. Huang BS and FH Leenen: Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension 34: 107-112, 1999. (Pubitemid 29325727)
8. Hamlyn JM, Hamilton BP and Manunta P: Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens 14: 151-167, 1996. (Pubitemid 26121856)
9. Ren YP, Huang RW and Lu ZR: Ouabain at pathological concentrations might induce damage in human vascular endothelial cells. Acta Pharmacol Sin 27: 165-172, 2006.
10. Yamakoshi J, Kataoka S, Koga T and Ariga T: Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 142: 139-149, 1999. (Pubitemid 28551819)
11. Duarte J, Pérez-Palencia R, Vargas F, Ocete MA, Pérez-Vizcaino F, Zarzuelo A and Tamargo J: Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 133: 117-124, 2001. (Pubitemid 32500458)
12. Koprdová R, Cebová M And Kristek F. Long-term effect of losartan administration on blood pressure, heart and structure of coronary artery of young spontaneously hypertensive rats. Physiol Res 58: 327-335, 2009.
13. Ferrandi M, Manunta P, Ferrari P and Bianchi G: The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications. Front Biosci 10: 2472-2477, 2005. (Pubitemid 40905251)
14. Schoner W and Scheiner-Bobis G: Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer. Semin Nephrol 25: 343-351, 2005. (Pubitemid 41749417)
15. Hamlyn JM, Ringel R, Schaeffer J, Levinson PD, Hamilton BP, Kowarski AA and Blaustein MP: A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension. Nature 300: 650-652, 1982. (Pubitemid 13253322)
16. Manunta P, Rogowski AC, Hamilton BP and Hamlyn JM: Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens 12: 549-560, 1994. (Pubitemid 24192880)
17. Xavier FE, Rossoni LV, Alonso MJ, Balfagón G, Vassallo DV and Salaices M: Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries.Br J Pharmacol 143: 215-225, 2004. (Pubitemid 39280041)
18. Bagchi D, Bagchi M, Stohs S, Ray SD, Sen CK and Preuss HG: Cellular protection with proanthocyanidins derived from grape seeds. Ann N Y Acad Sci 957: 260-270, 2002. (Pubitemid 34721670)
19. Sato M, Maulik G, Ray PS, Bagchi D and Das DK: Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. J Mol Cell Cardiol 31: 1289-1297, 1999. (Pubitemid 29276626)
20. Sato M, Ray PS, Maulik G, Maulik N, Engelman RM, Bertelli AA, Bertelli A and Das DK: Myocardial protection with red wine extract. J Cardiovasc Pharmacol 35: 263-268, 2000. (Pubitemid 30073818)
21. Facino RM, Carini M, Aldini G, Berti F, Rossoni G, Bombardelli E and Morazzoni P: Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post-ischaemic damage in rats. Life Sci 64: 627-642, 1999. (Pubitemid 29083176)
22. Sivaprakasapillai B, Edirisinghe I, Randolph J, Steinberg F and Kappagoda T: Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism 58: 1743-1746, 2009.
23. Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M and Morimoto S: Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol 114: 925-930, 1995.
24. Matsuoka H, Nishida H, Nomura G, Van Vliet BN and Toshima H: Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 23: 971-975, 1994. (Pubitemid 24180848)
25. Pollock DM, Polakowski JS, Divish BJ and Opgenorth TJ: Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21: 660-666, 1993. (Pubitemid 23120221)
26. Qiu C, Engels K and Baylis C: Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am J Physiol 266: R1470-1476, 1994.
27. Bujak M and Frangogiannis NG: The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74: 184-195, 2007. (Pubitemid 46517504)